SCHEMBL5249398

SCHEMBL5249398

CC(C)(C)OC(=O)N1CCCC(CN2CCN(C(=O)OCc3ccccc3)CC2)C1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.50
ACKR3 P25106 1/20 0.49
SMN1; SMN2 Q16637 3/20 0.48
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
HTT P42858 1/20 0.48
HTR6 P50406 4/20 0.47
BCHE P06276 2/20 0.47
FEN1 P39748 1/20 0.47
CYP2C19 P33261 1/20 0.47
USP30 Q70CQ3 1/20 0.47
CNR1 P21554 1/20 0.45
KAT7 O95251 1/20 0.45
KAT8 Q9H7Z6 1/20 0.45
JAK2 O60674 1/20 0.45
JAK1 P23458 1/20 0.45
GPR119 Q8TDV5 1/20 0.45
STS P08842 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1780154 1.00 PARP1 (0.50) PARP1ACKR3SMN1; SMN2NPC1RAB9A
SCHEMBL30602886 0.94 SMN1; SMN2 (0.53) PARP1SMN1; SMN2NPC1RAB9AHTT
SCHEMBL26705305 0.94 SMN1; SMN2 (0.53) PARP1SMN1; SMN2NPC1RAB9AHTT
SCHEMBL30179036 0.94 SMN1; SMN2 (0.53) PARP1SMN1; SMN2NPC1RAB9AHTT
SCHEMBL25338897 0.91 SMN1; SMN2 (0.50) PARP1SMN1; SMN2NPC1RAB9AHTT
SCHEMBL20046470 0.91 SMN1; SMN2 (0.50) PARP1SMN1; SMN2NPC1RAB9AHTT
SCHEMBL29132380 0.90 SMN1; SMN2 (0.54) PARP1SMN1; SMN2NPC1RAB9AHTT
SCHEMBL26925080 0.89 SMN1; SMN2 (0.52) PARP1SMN1; SMN2NPC1RAB9AHTT
SCHEMBL29579133 0.89 SMN1; SMN2 (0.49) PARP1SMN1; SMN2NPC1RAB9AHTT
SCHEMBL2386800 0.89 SMN1; SMN2 (0.56) SMN1; SMN2NPC1RAB9AHTTCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1831164-A1 HETEROCYCLIC COMPOUNDS AS CCR2B ANTAGONISTS AstraZeneca AB (SE) 2007-09-12 EP disclosed
WO-2006067401-A1 HETEROCYCLIC COMPOUNDS AS CCR2B ANTAGONISTS ASTRAZENECA AB (SE) 2006-06-29 WO disclosed